selected publications
- Clinicopathologic and Molecular Analysis of Primary Angiosarcoma of Bone-A Single Institution Experience. Genes, chromosomes & cancer. 2025 Academic Article GET IT
-
A Clinicopathologic and Molecular Reappraisal of Myxoinflammatory Fibroblastic Sarcoma-A Controversial and Pathologically Challenging Low-Grade Sarcoma.
Genes, chromosomes & cancer.
2025
Academic Article
GET IT
Times cited: 2 -
Cancer risk assessment of premalignant breast tissues from patients with BRCA mutations by genome profiling.
NPJ breast cancer.
2024
Academic Article
GET IT
Times cited: 2 - Translocation in bone and soft tissue sarcomas: a comprehensive epidemiological investigation. ESMO open. 2024 Academic Article GET IT
- Impact of COVID-19 pandemic on bone and soft tissue sarcoma patients' consultation and diagnosis. Scientific reports. 2024 Academic Article GET IT
- Effectiveness and safety of primary prophylaxis with G-CSF for patients with Ewing sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology. International journal of clinical oncology. 2024 Academic Article GET IT
- Primary prophylaxis with G-CSF for patients with non-round cell soft tissue sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology. International journal of clinical oncology. 2024 Academic Article GET IT
-
Immune evasion in lung metastasis of leiomyosarcoma: upregulation of EPCAM inhibits CD8+ T cell infiltration.
British journal of cancer.
2024
Academic Article
GET IT
Times cited: 1 -
Viable tumor cell density after neoadjuvant chemotherapy assessed using deep learning model reflects the prognosis of osteosarcoma.
NPJ precision oncology.
2024
Academic Article
GET IT
Times cited: 6 -
Extensive analysis of 59 sarcoma-related fusion genes identified pazopanib as a potential inhibitor to COL1A1-PDGFB fusion gene.
Cancer science.
2023
Academic Article
GET IT
Times cited: 4 -
Short-term clinical outcomes of Kyocera Modular Limb Salvage System designed cementless stems for the endoprosthetic reconstruction of lower extremities: a Japanese Musculoskeletal Oncology Group multi-institutional study.
BMC cancer.
2022
Academic Article
GET IT
Times cited: 7 -
Preclinical assessment of combination therapy of EGFR tyrosine kinase inhibitors in a highly heterogeneous tumor model.
Oncogene.
2022
Academic Article
GET IT
Times cited: 12 -
Methylation-mediated silencing of protein kinase C zeta induces apoptosis avoidance through ATM/CHK2 inactivation in dedifferentiated chondrosarcoma.
British journal of cancer.
2022
Academic Article
GET IT
Times cited: 8 -
MicroSEC filters sequence errors for formalin-fixed and paraffin-embedded samples.
Communications biology.
2021
Academic Article
GET IT
Times cited: 7 -
Does the Use of Peripheral Immune-Related Markers Indicate Whether to Administer Pazopanib, Trabectedin, or Eribulin to Advanced Soft Tissue Sarcoma Patients?.
Journal of clinical medicine.
2021
Academic Article
GET IT
Times cited: 6 -
The treatment landscape of advanced angiosarcoma in Asia-A multi-national collaboration from the Asian Sarcoma Consortium.
Cancer science.
2021
Academic Article
GET IT
Times cited: 14 -
Extensive functional evaluation of exon 20 insertion mutations of EGFR.
Lung cancer (Amsterdam, Netherlands).
2020
Academic Article
GET IT
Times cited: 20 -
Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma.
Oncogene.
2019
Academic Article
GET IT
Times cited: 59